Friday, July 10, 2026

pharma · Moderate to severe pain associated with Osteoarthritis of the knee · Not applicable for phase I study

Grünenthal

Grünenthal clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Aachen, DE HQ
4,668 Employees
EMA registrant Type
Company details
Status
Public
HQ
Aachen, DE
Employees
4,668
Programs
3
Drugs
5
Patents
0
Intelligence · Clinical Programs

Grünenthal projects

0 ClinicalTrials.gov programs sponsored by Grünenthal.

Grünenthal has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

No programs matched

Try a different phase filter or check back as we index more trials.

Frequently asked questions

How many clinical projects does Grünenthal have?

0 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.